Cargando…
Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis
Human African Trypanosomiasis (HAT) is an endemic protozoan disease widespread in the sub-Saharan region that is caused by T. b. gambiense and T. b. rhodesiense. The development of molecules targeting rhodesain, the main cysteine protease of T. b. rhodesiense, has led to a panel of inhibitors endowe...
Autores principales: | Previti, Santo, Ettari, Roberta, Di Chio, Carla, Ravichandran, Rahul, Bogacz, Marta, Hellmich, Ute A., Schirmeister, Tanja, Cosconati, Sandro, Zappalà, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229991/ https://www.ncbi.nlm.nih.gov/pubmed/35744891 http://dx.doi.org/10.3390/molecules27123765 |
Ejemplares similares
-
Development of Urea-Bond-Containing Michael Acceptors
as Antitrypanosomal Agents Targeting Rhodesain
por: Previti, Santo, et al.
Publicado: (2022) -
Drug Combination Studies of the Dipeptide Nitrile CD24 with Curcumin: A New Strategy to Synergistically Inhibit Rhodesain of Trypanosoma brucei rhodesiense
por: Di Chio, Carla, et al.
Publicado: (2022) -
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors
por: Previti, Santo, et al.
Publicado: (2023) -
Dipeptide Nitrile CD34 with Curcumin: A New Improved Combination Strategy to Synergistically Inhibit Rhodesain of Trypanosoma brucei rhodesiense
por: Di Chio, Carla, et al.
Publicado: (2023) -
Monoclonal Antibodies: The Greatest Resource to Treat Multiple Myeloma
por: De Luca, Fabiola, et al.
Publicado: (2023)